ICD-10 Coding for Keratoacanthoma(C44._, D48.5)
Complete ICD-10-CM coding and documentation guide for Keratoacanthoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Keratoacanthoma
C44._Primary Range
Malignant neoplasms of skin
Used when keratoacanthoma is confirmed as squamous cell carcinoma (SCC-KA type).
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C44._ | Malignant neoplasm of skin | Use when keratoacanthoma is confirmed as SCC-KA type. |
|
| D48.5 | Neoplasm of uncertain behavior of skin | Use when keratoacanthoma is not confirmed as malignant. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: keratoacanthoma icd 10 code
Essential facts and insights about Keratoacanthoma
Primary ICD-10-CM Codes for keratoacanthoma
Decision Criteria
clinical Criteria
- Biopsy confirms SCC-KA type.
Applicable To
- SCC-KA type
Excludes
- Benign keratosis
Clinical Validation Requirements
- Biopsy confirming SCC-KA type
- Histology showing well-differentiated SCC
Code-Specific Risks
- Misclassification as benign can lead to under-treatment.
Coding Notes
- Ensure biopsy confirms SCC-KA type before using this code.
D48.5 - Neoplasm of uncertain behavior of skin
Use when keratoacanthoma is not confirmed as malignant.
Applicable To
- Keratoacanthoma without confirmed malignancy
Excludes
- Malignant neoplasm of skin
Clinical Validation Requirements
- Histology inconclusive for SCC
- Observation of spontaneous regression
Coding Notes
Use when histology is inconclusive for malignancy.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Tanning bed exposure
W89.1XXADifferential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Keratoacanthoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C44._.
Impact
Clinical: Inaccurate risk assessment for skin cancer., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials for lack of medical necessity.
Mitigation Strategy
Always ask about UV exposure during patient history., Include UV exposure in the medical record.
Impact
Reimbursement: Incorrect coding can lead to denial of claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation Strategy
Confirm with pathology before coding as malignant.
Impact
Coding without biopsy confirmation of SCC-KA.
Mitigation Strategy
Require biopsy reports before finalizing codes.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Keratoacanthoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Keratoacanthoma
Use these documentation templates to ensure complete and accurate documentation for Keratoacanthoma. These templates include all required elements for proper coding and billing.
Keratoacanthoma with suspected malignancy
Specialty: DermatologyRequired Elements
- Lesion size and location
- Growth rate
- Biopsy results
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Keratoacanthoma? Ask your questions below.